Related Experiment Videos
[Tachyphylaxis in timolol therapy for chronic glaucoma (author's transl)]
Summary
Timolol eye drops effectively lowered intraocular pressure in glaucoma patients initially. However, many developed rapid tolerance (tachyphylaxis), leading to high eye pressure, even higher than before treatment.
Area of Science:
- Ophthalmology
- Pharmacology
Context:
- Open-angle glaucoma is a leading cause of irreversible blindness.
- Effective intraocular pressure (IOP) lowering is crucial for managing glaucoma progression.
Purpose:
- To evaluate the efficacy and incidence of tachyphylaxis with topical 0.5% Timolol in open-angle glaucoma patients.
Summary:
- Initial remarkable IOP reduction was observed in 43 open-angle glaucoma patients treated with 0.5% Timolol.
- 14 patients (32.5%) developed tachyphylaxis within 2-3 days, with some cases persisting for two months.
- In some tachyphylactic cases, IOP exceeded pre-treatment levels, indicating treatment failure.
Impact:
- Highlights the potential for rapid tachyphylaxis with Timolol, impacting long-term glaucoma management.
- Suggests careful monitoring for treatment response and potential tachyphylaxis is necessary for Timolol therapy.